National assessment of recommendations from healthcare providers for smoking cessation among adults with cancer
Original price was: $24.59.$2.99Current price is: $2.99.
- Title : National assessment of recommendations from healthcare providers for smoking cessation among adults with cancer
- Author: Richard S. Matulewicz a,b,*,1, Zachary Feuer b,c,1, Sarah A. Birken e, Danil V. Makarov b,c,Scott E. Sherman b,f, Marc A. Bjurlin d,1, Omar El Shahawy f,
- Publication: Cancer Epidemiology
- Publisher: Elsevier Inc
- Year: 2022
- Language: English
- Pages: 5
- Format: PDF
- File size: 330 KB
- DOI: 10.1016/j.canep.2021.102088
- CBID: CBR217
Abstract
Cancer survivors benefit from evidence-based smoking cessation treatment. A crucial first step in this process is a clinician recommending that the patient quit smoking. However, contemporary delivery of advice to quit among patients with cancer is not well known. In a cross-sectional analysis of all adult smokers included in a prospective population-representative study of US adults, we analyzed the frequency that patients reported receiving advice to quit smoking from a healthcare professional according to reported cancer history (no cancer, tobacco-related cancer, non-tobacco related cancer history). Among an estimated 28.3 million smokers, 9.3% reported a history of cancer, 48.8% of which were tobacco-related cancers. In general, advice to quit was reported by more (67.8%) cancer survivors than those adults without any cancer (56.0%). After adjustment for sociodemographic factors, smokers with a non tobacco-related cancer (0.51, 95% CI 0.32–0.83) and those without any cancer history (0.43, 95% CI 0.30–0.63) were both less likely to report being advised to quit smoking than patients with a tobacco-related cancer history.
Highlights
- • Smokers with a cancer diagnosis are more likely to be advised to quit smoking.
- • One-third of smokers with cancer history did not receive cessation counseling.
- • Smokers receiving cessation counseling were twice as likely to receive pharmacotherapy.
1Introduction
Tobacco use is a leading cause of cancer and mortality in United States adults. Smoking cessation treatment is a critical component of cancer survivorship since those who quit have better outcomes and longer survival . Guideline recommended treatment includes clinician counseling and use of pharmacotherapy . Use of tobacco cessation counseling in the general population is well-described .
The association between cessation rates after counseling amongst patients with and without cancer has been studied . Nevertheless, offering of cessation counseling, specifically for smokers with cancer, has been relatively understudied despite the established benefits in this vulnerable population . This is especially important given that continued smoking after a cancer diagnosis has been associated with poor outcomes .
Understanding the prevalence and correlates of smoking cessation care given to cancer survivors at the population level can help inform future interventions aimed at improving the use of evidence-based treatments. Using a population-based cohort, we aim to determine whether adults with cancer are more or less likely to report being advised to quit smoking than those without cancer. Further, we aim to demonstrate that this recommendation is associated with the use of evidence-based pharmacotherapies.
Be the first to review “National assessment of recommendations from healthcare providers for smoking cessation among adults with cancer”
Related products
Reviews
There are no reviews yet.